STOCK TITAN

iSpecimen (NASDAQ: ISPC) commits $2M to three‑month IR marketing pact

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

iSpecimen Inc. entered into a Consulting Agreement with IR Agency LLC on August 12, 2026. The consultant will provide non-exclusive marketing and news distribution services to the financial community for a three‑month term, covering up to ten news releases. iSpecimen agreed to pay a fully earned, non‑refundable $2,000,000 cash fee by August 13, 2026. Either party may terminate at any time on written notice, but iSpecimen will not receive a refund if it terminates during the initial term. The consultant will not solicit orders or provide investment advice and must comply with U.S. securities laws. The agreement includes provisions on promotional disclosures, confidentiality, material non‑public information, indemnification, liability limitations and binding arbitration in New Jersey.

Positive

  • None.

Negative

  • $2,000,000 marketing fee is fully earned, non‑refundable, and payable up front for a three‑month term, creating a sizable cash outlay even if services are reduced or terminated early.

Filing Explained

The new liquidity read is that the fee is an obligation to pay, not a reported payment: it sits alongside $4,414,364 of cash and equivalents at June 30, while that balance equals 576.1 days of the latest quarter’s operating cash use.

Sources and calculations
  • Cash and equivalents vs quarterly operating cash outflow, in days of cash use $4,414,364 / ($689,625 / 90) = [object Object]
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Consulting fee $2,000,000 Aggregate cash fee payable to IR Agency LLC by August 13, 2026
Term length three-month term Initial term of consulting services commencing on August 12, 2026
Maximum news releases ten news releases Maximum number of news releases covered during the three-month term
Agreement date August 12, 2026 Date iSpecimen entered into the Consulting Agreement with IR Agency LLC
Material Definitive Agreement regulatory
"Item 1.01. Entry into a Material Definitive Agreement."
A material definitive agreement is a legally binding contract that creates major, long‑term obligations or rights for a company, such as loans, asset sales, mergers, or supplier deals. Think of it like a mortgage or lease for a business: it can change future cash flow, risk and control, so investors watch these agreements closely because they can materially affect a company’s value, financial health and stock price.
indemnification legal
"The Consulting Agreement also contains provisions relating to ... indemnification by the Company"
A contractual promise to cover losses, expenses, or legal claims that arise from specified events, such as breaches of representations or third‑party lawsuits. For investors, indemnification matters because it shifts potential financial risk and future cash outflows from one party to another, similar to a friend agreeing to pay your bill if you’re sued, and can affect deal value, expected returns, and contingent liabilities on the balance sheet.
limitations of the Consultant’s liability legal
"The Consulting Agreement also contains provisions relating to ... limitations of the Consultant’s liability"
binding arbitration legal
"The Consulting Agreement also contains provisions relating to ... binding arbitration in New Jersey."
A private process for resolving legal disputes where an impartial expert (the arbitrator) hears both sides and issues a decision instead of a court. Think of it as using a referee instead of going to a public trial; the outcome is usually final and appeals are limited. Investors care because binding arbitration can change how quickly and cheaply disputes are settled, limit public disclosure of issues, and affect shareholders’ ability to pursue broad class actions or seek full remedies in court.
material non-public information regulatory
"provisions relating to ... confidentiality and material non-public information"
Material non-public information is important news about a company that hasn't been shared with the public yet, like a secret that could affect its stock price. Using this inside information to buy or sell stocks is unfair and illegal because it gives someone an unfair advantage over others who don’t have the same info.

FAQ

What material agreement did iSpecimen (ISPC) enter into on August 12, 2026?

iSpecimen entered into a Consulting Agreement with IR Agency LLC for marketing and advertising services aimed at the financial community, including company profiles and media distribution over a three‑month term.

How much will iSpecimen (ISPC) pay IR Agency LLC under the new consulting agreement?

iSpecimen agreed to pay an aggregate cash fee of $2,000,000 to IR Agency LLC by August 13, 2026. The fee is fully earned upon receipt, non‑refundable, and covers up to ten news releases over the three‑month term.

What services will IR Agency LLC provide to iSpecimen (ISPC)?

IR Agency LLC will provide marketing and news distribution services, including creating company profiles and distributing up to ten news releases to communicate information about iSpecimen to the financial community.

Can iSpecimen (ISPC) terminate the consulting agreement and recover any of the fee?

Either party may terminate the agreement at any time upon written notice, but if iSpecimen terminates during the initial term, no portion of the $2,000,000 fee is refundable, regardless of remaining services.

Does IR Agency LLC provide investment advice or solicit trades for iSpecimen (ISPC)?

IR Agency LLC has agreed it will not solicit orders, make investment recommendations, provide investment advice, or effect securities transactions, and will comply in all material respects with applicable U.S. securities laws.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001558569 0001558569 2026-08-12 2026-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 12, 2026

 

iSpecimen Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40501   27-0480143
(State or other jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

8 Cabot Road, Suite 1800
Woburn, MA 01801

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (781) 301-6700

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On August 12, 2026, iSpecimen Inc. (the “Company”) entered into a Consulting Agreement (the “Consulting Agreement”) with IR Agency LLC (the “Consultant”), pursuant to which the Consultant agreed to provide marketing and advertising services designed to communicate information about the Company to the financial community, including the creation of company profiles and media distribution.

 

The Consulting Agreement provides for a three-month term commencing on August 12, 2026, during which the Consultant will provide marketing and news distribution services for a maximum of ten news releases. The Consultant will act as an independent contractor, and the services provided under the Consulting Agreement are non-exclusive.

 

In consideration for the services to be provided under the Consulting Agreement, the Company agreed to pay the Consultant an aggregate cash fee of $2,000,000 by August 13, 2026. The fee is fully earned upon receipt and is non-refundable. The Company may request that the term be extended for months during which no news distribution services are performed, and any additional or out-of-scope services will be subject to separate compensation arrangements.

 

Either party may terminate the Consulting Agreement, with or without cause, at any time upon written notice to the other party. If the Company terminates the Consulting Agreement during the initial term for any reason, the Company will not be entitled to a refund of any portion of the compensation paid. The Consultant may immediately suspend or terminate the services if it believes continued performance may expose it to legal, regulatory or reputational risk, in which case no refund will be owed.

 

The Consultant has agreed that it will not solicit orders, make investment recommendations, provide investment advice or effect securities transactions, and that it will comply in all material respects with applicable U.S. securities laws in performing the services. The Consulting Agreement also contains provisions relating to the accuracy and approval of Company information and promotional materials, paid-promotion disclosures, confidentiality and material non-public information, indemnification by the Company, limitations of the Consultant’s liability and binding arbitration in New Jersey.

 

The foregoing description of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Consulting Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
10.1   Consulting Agreement, dated August 12, 2026, by and between iSpecimen Inc. and IR Agency LLC.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: August 14, 2026

 

  iSPECIMEN INC.
     
  By: /s/ Katharyn Field
    Name: Katharyn Field
    Title: Chief Executive Officer

 

2

 

Filing Exhibits & Attachments

4 documents